Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Regeneron Pharmaceuticals, Inc.(REGN) Shareholders
NEW YORK CITY, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment ...
REGENERON EXPANDS PRESENCE IN CANADA BY OPENING ITS FIRST HEADQUARTERS TO BETTER SERVE NEEDS OF CANADIANS WITH SERIOUS DISEASES
Regeneron Canada Company today officially opened its first headquarters that will allow it to better serve the needs of ...
Jim Cramer on Regeneron Pharmaceuticals, Inc. (REGN): ‘This Company Has Never Lost Its Ability To Develop New Medicines’
We recently compiled a list of the 9 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where ...
FiercePharma7d
JPM25: Regeneron CEO says it needs more 'arrows in its quiver' as Eylea HD sales fall short
After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company ...
Daily Camera35m
Nederland senior named a Regeneron Science Talent Search scholar
Keahi Pelkum Donahue, a senior at Nederland Middle Senior High School, recently was named one of the top 300 scholars in the Regeneron Science Talent Search.
Pharma giant Regeneron is spending $119.5M on the world’s largest, most diverse genetic database using DNA from patient volunteers
The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...
Regeneron Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
Regeneron Pharmaceuticals Inc. closed 42.77% short of its 52-week high of $1,211.20, which the company achieved on August ...
Aaron Wealth Advisors LLC Trims Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Aaron Wealth Advisors LLC cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 22.4% in the 4th quarter, according to its most recent disclosure with the Securities and ...
Regeneron Pharmaceuticals, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the REGN Class Action
SAN DIEGO, CA / ACCESSWIRE / January 15, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
BioSpace7d
Where Keytruda Failed, Regeneron Touts Phase III Skin Cancer Win for Libtayo
The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...
Regeneron: Phase III Success In Skin Cancer For Libtayo
Regeneron shares have been in a bearish trend since August, losing over one third of their value. Read why I am initiating ...
FierceBiotech8d
JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project
Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts of ...